News & Perspective

Sep 27, 2019

Sep 27, 2019

ASP Scan (Weekly) for Sep 27, 2019

Molecular test for blood infections
Rapid TB test assessment
CRE risk in Europe
Cefto-tazo for nosocomial pneumonia
XDR typhoid in Taiwan
UK antimicrobial resistance funds
CARB-X diagnostic graduate
Outpatient antibiotic prescribing
Hospital Candida auris outbreak
AMR Challenge commitments
UK prescribing letter

Mar 05, 2019

Mar 05, 2019

News Scan for Mar 05, 2019

FDA chief resigns
MMR vaccine not tied to autism (again)
MERS across Saudi Arabia
Lassa fever decline in Nigeria
Global flu update

Oct 05, 2018

Oct 05, 2018

ASP Scan (Weekly) for Oct 05, 2018

MRSA de-colonization of therapy dogs
Multiple Candida auris introductions
Early stewardship interventions
Bacteriophage clinical trial
Improper antibiotic prescribing in China
Point-of-care flu tests and antibiotics
New tetracycline approved
Combo antibiotic for CRE
Telemedicine and antibiotic prescribing
FDA approves new antibiotic
Linezolid resistance in food animals
Water consumption and UTIs

Sep 16, 2016

Sep 16, 2016

ASP Scan (Weekly) for Sep 16, 2016

Colistin resistance in France
NDM-1 in Vibrio isolates
MDR-TB cure rates
Multidrug-resistant CRE
MDR pathogens in Syrian kids
New C diff antibiotic
Bacteria in water

Jun 04, 2010

Jun 04, 2010

BMJ, European group criticize WHO pandemic actions

(CIDRAP News) – An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»